The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer’s disease
Open accessAbstract
Double-transgenic amyloid precursor protein/presenilin 1 (APP/PS1) mice express a chimeric mouse/human APP bearing the Swedish mutation (Mo/HuAPP695swe) and a mutant human PS1-dE9 both causative of familial Alzheimer's disease (FAD). Transgenic mice show impaired memory and learning performance from the age of 6 months onwards. Double-transgenic APP/PS1 mice express altered APP and PS1 mRNAs and proteins, reduced β-secretase 1 (BACE1) mRNA and normal BACE1 protein, all of which suggest a particular mechanism of amyloidogenesis when compared with sporadic AD. The first β-amyloid plaques in APP/PS1 mice appear at 3 months, and they increase in number and distribution with disease progression in parallel with increased levels of brain soluble β-amyloid 1-42 and 1-40, but also with reduced 1-42/1-40 ratio with age. Amyloid deposition in plaques is accompanied by altered mitochondria and increased oxidative damage, post-translational modifications and accumulation of altered proteins at the dystrophic neurites surrounding plaques. Degradation pathways are also modified with disease progression including activation of the immunoproteasome together with variable alterations of the different protease activities of the ubiquitin-proteasome system. Present observations show modifications in the production of β-amyloid and activation and malfunction of the subcellular degradation pathways that have general implications in the pathogenesis of AD and more particularly in specificities of FAD amyloidogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IHC for SOD1 labels areas of high oxidative stress, specifically around Aβ plaques, and is associated with dystrophic neurites [21,48].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [48]
In the citing paper
“Elevated SOD expression is indicative of the high levels of oxidative stress associated with Aβ plaques in Alzheimer’s disease brains [21,48,80,104].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [48]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,304
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Anderson, J. P., Walker, D., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600933200 · Cited by 1,452
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., & Brinton, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903563106 · Cited by 940
Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017033108 · Cited by 876
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Cited by
Sorted by citations
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
Bachiller, S., Jiménez-Ferrer, I., Paulus, A., Yang, Y., Swanberg, M., Deierborg, T., & Boza‐Serrano, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00488 · Cited by 750
Moldogazieva, N. T., Mokhosoev, I. M., Melnikova, T. I., Porozov, Y. B., & Terentiev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3085756 · Cited by 510
A Practical Review of Proteasome Pharmacology
Thibaudeau, T. A., & Smith, D. M. (2019) · Pharmacological Reviews · doi:10.1124/pr.117.015370 · Cited by 354
The cerebellum in Alzheimer’s disease: evaluating its role in cognitive decline
Jacobs, H. I. L., Hopkins, D. A., Mayrhofer, H. C., Bruner, E., van Leeuwen, F. W., Raaijmakers, W., & Schmahmann, J. D. (2017) · Brain · doi:10.1093/brain/awx194 · Cited by 349
Dantuma, N. P., & Bott, L. C. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00070 · Cited by 354
CB 2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
Aso, E., Juvés, S., Maldonado, R. J., & Ferrer, I. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130137 · Cited by 211
Self-citationPedrós, I., Petrov, D., Allgaier, M., Sureda, F. X., Barroso, E., Beas‐Zárate, C., Auladell, C., Pallàs, M., Vázquez‐Carrera, M., Casadesús, G., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.025 · Cited by 211
Blanch, M., Mosquera, J. L., Ansoleaga, B., Ferrer, I., & Barrachina, M. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.10.004 · Cited by 192
Self-citationReactive glia show increased immunoproteasome activity in Alzheimer’s disease
Orre, M., Kamphuis, W., Dooves, S., Kooijman, L., Chan, E. T., Kirk, C. J., Dimayuga Smith, V., Koot, S., Mamber, C., Jansen, A. H., et al. (2013) · Brain · doi:10.1093/brain/awt083 · Cited by 180
Neuroprotective Role of Trans-Resveratrol in a Murine Model of Familial Alzheimer's Disease
Porquet, D., Griñán‐Ferré, C., Ferrer, I., Camins, A., Sanfeliu, C., del Valle, J., & Pallàs, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140444 · Cited by 180
Self-citationFerrer, I. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.005 · Cited by 174
Self-citationFabelo, N., Martín, M. V., Marín, R., Moreno, D., Ferrer, I., & Díaz, M. L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.005 · Cited by 169
Self-citationCannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice
Aso, E., Sánchez-Pla, A., Vegas-Lozano, E., Maldonado, R., & Ferrer, I. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141014 · Cited by 154
Self-citationGupta, V. B., Chitranshi, N., den Haan, J., Mirzaei, M., You, Y., Lim, J. K. H., Basavarajappa, D. K., Godinez, A., Angelantonio, S. D., Sachdev, P. S., et al. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100899 · Cited by 149
Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice
López‐González, I., Schlüter, A., Aso, E., Garcia‐Esparcia, P., Ansoleaga, B., Llorens, F., Carmona, M., Moreno, J. R., Fuso, A., Portero‐Otín, M., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000176 · Cited by 128
Self-citationDistinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease.
Pera, M., Alcolea, D., Sánchez-Valle, R., Guardia-Laguarta, C., Colom-Cadena, M., Badiola, N., Suárez-Calvet, M., Lladó, A., Barrera-Ocampo, A. A., Sepulveda-Falla, D., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1062-9 · Cited by 115
Self-citationCB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
Aso, E., Palomer, E., Juvés, S., Maldonado, R. J., Muñoz, F. J., & Ferrer, I. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111862 · Cited by 122
Self-citationScassellati, C., Galoforo, A. C., Bonvicini, C., Esposito, C., & Ricevuti, G. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101138 · Cited by 126
Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and Disease
Ferrer, I., Garcia‐Esparcia, P., Carmona, M., Carro, E., Aronica, E., Kovács, G. G., Grison, A., & Gustincich, S. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00163 · Cited by 118
Self-citationFleitas, C., Piñol‐Ripoll, G., Marfull‐Oromí, P., Rocandio, D., Ferrer, I., Rampon, C., Egea, J., & Espinet, C. (2018) · Molecular Brain · doi:10.1186/s13041-018-0411-6 · Cited by 104
Self-citationStructure, Dynamics and Function of the 26S Proteasome
Mao, Y. (2020) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-58971-4_1 · Cited by 111
The Proteasome and Oxidative Stress in Alzheimer's Disease
Bonet-Costa, V., Pomatto, L. C.-D., & Davies, K. J. A. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6802 · Cited by 99
Aso, E., Martinsson, I., Appelhans, D., Effenberg, C., Benseny‐Cases, N., Cladera, J., Gouras, G. K., Ferrer, I., & Klementieva, O. L. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.010 · Cited by 101
Self-citationProteasome activation delays aging in vitro and in vivo
Chondrogianni, N., Sakellari, M., Lefaki, M., Papaevgeniou, N., & Gonos, E. S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.031 · Cited by 94
Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice
Matthews, D. G., Caruso, M., Murchison, C. F., Zhu, J. Y., Wright, K. M., Harris, C. J., Gray, N. E., Quinn, J. F., & Soumyanath, A. (2019) · Antioxidants · doi:10.3390/antiox8120630 · Cited by 86
“Elevated SOD expression is indicative of the high levels of oxidative stress associated with Aβ plaques in Alzheimer’s disease brains [21,48,80,104].”
BackgroundDysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model
Ansoleaga, B., Garcia‐Esparcia, P., Llorens, F., Moreno, J., Aso, E., & Ferrer, I. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.06.034 · Cited by 84
Self-citationProteostasis Disturbances and Inflammation in Neurodegenerative Diseases
Sonninen, T.-M., Goldsteins, G., Laham-Karam, N., Koıstınaho, J., & Lehtonen, Š. (2020) · Cells · doi:10.3390/cells9102183 · Cited by 89
Wang, C., Wang, Z., Xie, J., Wang, T., Wang, X., Xu, Y., & Cai, J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.024 · Cited by 81
Puig, K. L., Lutz, B. M., Urquhart, S. A., Rebel, A. A., Zhou, X., Manocha, G. D., Sens, M. A., Tuteja, A. K., Foster, N. L., & Combs, C. K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142259 · Cited by 80
Díaz, M. L., Fabelo, N., Martín, M. V., Ferrer, I., Gómez, T., & Marín, R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141146 · Cited by 75
Self-citationFabelo, N., Martín, M. V., Marín, R., Santpere, G., Aso, E., Ferrer, I., & Díaz, M. L. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31826be03c · Cited by 76
Self-citationKlementieva, O. L., Aso, E., Filippini, D., Benseny‐Cases, N., Carmona, M., Juvés, S., Appelhans, D., Cladera, J., & Ferrer, I. (2013) · Biomacromolecules · doi:10.1021/bm400948z · Cited by 74
Self-citationA Sentinel in the Crosstalk Between the Nervous and Immune System: The (Immuno)-Proteasome
Limanaqi, F., Biagioni, F., Gaglione, A., Busceti, C. L., & Fornai, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00628 · Cited by 69
Casañas‐Sánchez, V., Pérez, J. A. P., Fabelo, N., Quinto‐Alemany, D., & Díaz, M. L. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00203 · Cited by 66
Self-citationLi, X., Men, W., Zhu, H., Lei, J., Zuo, F., Wang, Z., Zhu, Z., Bao, X., & Wang, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101707 · Cited by 66
Helin, J. S., Lopez‐Picon, F. R., Majidi, R. A., Eskola, O., Krzyczmonik, A., Keller, T., Löyttyniemi, E., Solin, O. H., Rinne, J. O., & Haaparanta‐Solin, M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16677990 · Cited by 66
Wagner, L. K., Gilling, K. E., Schormann, E., Kloetzel, P. M., Heppner, F. L., Krüger, E., & Prokop, S. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0453-5 · Cited by 67
Mirzaei, M., Pushpitha, K., Deng, L., Chitranshi, N., Gupta, V. B., Rajput, R., Mangani, A. S., Dheer, Y., Godinez, A., McKay, M. J., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1479-4 · Cited by 60
Lachén‐Montes, M., González-Morales, A., de Morentin, X. M., Pérez‐Valderrama, E., Ausín, K., Zelaya, M. V., Serna, A., Aso, E., Ferrer, I., Fernández‐Irigoyen, J., et al. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.07.032 · Cited by 61
Self-citationPorquet, D., Andrés-Benito, P., Griñán-Ferré, C., Camins, A., Ferrer, I., Canudas, A. M., Del Valle, J., & Pallàs, M. (2015) · AGE · doi:10.1007/s11357-015-9747-3 · Cited by 53
Self-citationAltered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.
Garcia‐Esparcia, P., Sideris-Lampretsas, G., Hernández‐Ortega, K., Grau‐Rivera, O., Sklaviadis, T., Gelpí, E., & Ferrer, I. (2017) · Europe PMC (PubMed Central) · Cited by 53
Self-citationMethylglyoxal Formation—Metabolic Routes and Consequences
Vašková, J., Sabolová, G., Pudelský, J., Palenčár, D., & Mičková, H. (2025) · Antioxidants · doi:10.3390/antiox14020212 · Cited by 61
Casañas‐Sánchez, V., Pérez, J. A. P., Fabelo, N., Herrera‐Herrera, A. V., Fernández, C., Marín, R., González-Montelongo, M. D. C., & Díaz, M. L. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12833 · Cited by 48
Self-citationGlial Activation in AβPP/PS1 Mice is Associated with Infiltration of IFNγ-Producing Cells
Kelly, R. J., Minogue, A. M., Lyons, A., Jones, R. S., Browne, T. C., Costello, D. A., Denieffe, S., O'Sullivan, C., Connor, T. J., & Lynch, M. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130539 · Cited by 51
Launay, N., Ruíz, M., Fourcade, S., Schlüter, A., Guilera, C., Ferrer, I., Knecht, E., & Pujol, A. (2013) · Brain · doi:10.1093/brain/aws370 · Cited by 50
Self-citationAβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging
Ordóñez‐Gutiérrez, L., Fernandez-Perez, I., Herrera, J. L., Anton, M., Benito‐Cuesta, I., & Wandosell, F. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160572 · Cited by 47
Fernández-Echevarría, C., Díaz, M. L., Ferrer, I., Canerina‐Amaro, A., & Marín, R. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.079 · Cited by 44
Self-citationKempf, S. J., Metaxas, A., Ibáñez-Vea, M., Darvesh, S., Finsen, B. R., & Larsen, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.9092 · Cited by 44
Izco, M., Martinez, P. M., Corrales, A., Fandos, N., García-Cerro, S., Insua, D., Montañés, M., Pérez‐Grijalba, V., Rueda, N., Vidal, V., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.003 · Cited by 46
Aso, E., Andrés‐Benito, P., & Ferrer, I. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.007 · Cited by 45
Self-citationUgras, S. E., Daniels, M. J., Fazelinia, H., Gould, N. S., Yocum, A. K., Luk, K. C., Luna, E., Ding, H., McKennan, C. G., Seeholzer, S. H., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.05.007 · Cited by 40
Stuart, K. E., King, A. E., Fernández-Martos, C. M., Dittmann, J., Summers, M. J., & Vickers, J. C. (2016) · The Journal of Comparative Neurology · doi:10.1002/cne.24156 · Cited by 39
Failure of Ubiquitin Proteasome System: Risk for Neurodegenerative Diseases
Chen, Z., Geetha, T., & Babu, J. R. (2014) · Neurodegenerative Diseases · doi:10.1159/000367694 · Cited by 42
Armand‐Ugón, M., Aso, E., Moreno, J. R., Riera‐Codina, M., Sánchez‐Pla, Á., Vegas, E., & Ferrer, I. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141389 · Cited by 38
Self-citationLMP2 Inhibitors as a Potential Treatment for Alzheimer’s Disease
Bhattarai, D., Lee, M. J., Baek, A., Yeo, I. J., Miller, Z. C., Baek, Y. M., Lee, S., Kim, D., Hong, J. T., & Kim, K. B. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00416 · Cited by 36
Díaz, M. L., Fabelo, N., & Marín, R. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00454 · Cited by 34
Self-citationYue, X., Zhou, Y., Qiao, M., Zhao, X., Huang, X. H., Zhao, T., Cheng, X., Fan, M., Zhao, Y., Chen, R., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00935-z · Cited by 30
Yeo, I. J., Lee, M. J., Baek, A., Miller, Z. C., Bhattarai, D., Baek, Y. M., Jeong, H. J., Kim, Y. K., Kim, D., Hong, J. T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54846-z · Cited by 29
Mezencev, R., & Chernoff, Y. O. (2020) · Cancers · doi:10.3390/cancers12040796 · Cited by 27
Gvazava, N., Konings, S. C., Cepeda-Prado, E., Skoryk, V. R., Umeano, C. H., Dong, J., Silva, I. A. N., Ottosson, D. R., Leigh, N. D., Wagner, D. E., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c08854 · Cited by 26
Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice
Kennard, J. A., & Harrison, F. E. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.044 · Cited by 26
Lomoio, S., López‐González, I., Aso, E., Carmona, M., Torrejón-Escribano, B., Scherini, E., & Ferrer, I. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112198 · Cited by 27
Self-citationSantos, G., Díaz, M. L., & Torres, N. V. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00090 · Cited by 26
Self-citationEarly loss of cerebellar Purkinje cells in human and a transgenic mouse model of Alzheimer’s disease
Chaudhari, K., Wang, L., Kruse, J. J., Winters, A., Sumien, N., Shetty, R. A., Prah, J., Liu, R., Shi, J., Forster, M. J., et al. (2021) · Neurological Research · doi:10.1080/01616412.2021.1893566 · Cited by 24
Mitochondrial quality control: Epigenetic signatures and therapeutic strategies
Ambekar, T., Pawar, J., Rathod, R., Patel, M., Fernandes, V., Kumar, R., Singh, S. B., & Khatri, D. K. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105095 · Cited by 23
Church, T. R., & Margolis, S. S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1531797 · Cited by 25
Díaz, M. L., Fabelo, N., Casañas‐Sánchez, V., Marín, R., Gómez, T., Quinto‐Alemany, D., & Pérez, J. A. P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150470 · Cited by 21
Self-citationEttcheto, M., Petrov, D., Pedrós, I., de Lemos, L., Pallàs, M., Alegret, M., Laguna, J. C., Folch, J., & Camins, A. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.03.010 · Cited by 22
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 25
Self-citationImmunoproteasome is up-regulated in rotenone-induced Parkinson’s disease rat model
Sun, C., Jia, G., Wang, X., Wang, Y., & Liu, Y. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135360 · Cited by 20
Benseny‐Cases, N., Álvarez-Marimon, E., Aso, E., Carmona, M., Klementieva, O. L., Appelhans, D., Ferrer, I., & Cladera, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-96379-4 · Cited by 20
Self-citationZhang, J., Yu, L., Yang, H., Hui, Z., Jiang, S., Chen, L., Zhao, Y., Wang, S., Liu, Y., & Xu, Y. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2237-2 · Cited by 18
Intestinal homeostasis disrupted by Periodontitis exacerbates Alzheimer’s Disease in APP/PS1 mice
Qian, X., Lin, X., Hu, W., Zhang, L., Chen, W., Zhang, S., Ge, S., Xu, X., & Luo, K. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03256-8 · Cited by 17
Targeting immunoproteasome in neurodegeneration: A glance to the future
Tundo, G. R., Cascio, P., Milardi, D., Santoro, A. M., Graziani, G., Lacal, P. M., Bocedi, A., Oddone, F., Parravano, M., Coletta, A., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108329 · Cited by 19
Türker, F., Bharadwaj, R. A., Kleinman, J. E., Weinberger, D. R., Hyde, T. M., White, C. J., Williams, D. W., & Margolis, S. S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104811 · Cited by 16
Zhang, Y., & Wang, P. (2018) · Medical Science Monitor · doi:10.12659/msm.909596 · Cited by 15
The unique neuropathological vulnerability of the human brain to aging
Ferrer, I. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101916 · Cited by 15
Self-citationLiu, J., Lin, Y., Yang, Y., Guo, Y., Shang, Y., Zhou, B., Liu, T., Fan, J., & Wei, C. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115149 · Cited by 12
Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice
Abad, S., Ramon‐Duaso, C., López‐Arnau, R., Folch, J., Pubill, D., Camarasa, J., Camins, A., & Escubedo, E. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855987 · Cited by 12
Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer’s Disease
Park, J. E., Chaudhary, C. L., Bhattarai, D., & Kim, K. B. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02488 · Cited by 12
Ugarte, A., Corbacho, D., Aymerich, M. S., García‐Osta, A., Cuadrado‐Tejedor, M., & Oyarzábal, J. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0624-5 · Cited by 11
Mo, M., Li, G.-H., Sun, C., Huang, S., Wei, L., Zhang, L., Zhou, M., Wu, Z., Guo, W., Yang, X., et al. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0125-9 · Cited by 11
Su, D., Chai, Y.-N., Yang, J., Wang, X., Liu, Y. M., Ma, J., Tang, X., Mishra, C. K., Chandra, S. R., Yue, W., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.633805 · Cited by 12
Shen, H., Nie, J., Li, G., Tian, H., Zhang, J., Luo, X., Xu, D., Sun, J., Zhang, D., Zhang, H., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310872 · Cited by 9
Lipid Rafts and Development of Alzheimer’s Disease
Díaz, M. L., & Marín, R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94608 · Cited by 9
Self-citationJiang, J., Deng, J., Zhao, Y., Zhao, S., Niazi, N. U. K., Ge, Y., & Yang, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114591 · Cited by 9
SARS-CoV-2 amyloid, is COVID-19-exacerbated dementia an amyloid disorder in the making?
Milton, N. G. N. (2023) · Frontiers in Dementia · doi:10.3389/frdem.2023.1233340 · Cited by 8
Guo, Y., Wang, S., Li, L., Zhang, H., Chen, X., Huang, Z., & Liu, Y. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03564-9 · Cited by 8
Aso, E., Serrano, A. L., Muñoz‐Cánoves, P., & Ferrer, I. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142928 · Cited by 7
Self-citationproNGF Involvement in the Adult Neurogenesis Dysfunction in Alzheimer’s Disease
Olabiyi, B. F., Fleitas, C., Zammou, B., Ferrer, I., Rampon, C., Egea, J., & EspinetMestre, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910744 · Cited by 7
Self-citationDíaz, M. L. (2024) · Genes · doi:10.3390/genes15060810 · Cited by 6
Self-citationAbedi, A., Foroutan, T., Shalmani, L. M., & Dargahi, L. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109675 · Cited by 6
Benseny‐Cases, N., Álvarez-Marimon, E., Aso, E., Carmona, M., Klementieva, O. L., Appelhans, D., Ferrer, I., & Cladera, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-62708-2 · Cited by 6
Self-citationRetractedLü, Z., Zhou, H., Tang, H., Luo, S., Wang, J., Zheng, X., Hu, Y., Qin, Q., Yang, Q., Mo, S., et al. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251400239 · Cited by 3
Morozov, A. V., Burov, A. V., Funikov, S. Y., Teterina, E. V., Astakhova, T. M., Erokhov, P. A., Ustyugov, A. A., & Карпов, В. Л. (2023) · Molecular Biology · doi:10.1134/s0026893323050138 · Cited by 3
Glycodendrimers as Potential Multitalented Therapeutics in Alzheimer’s Disease
Klementieva, O. L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88974 · Cited by 3
Arisi, I., D’Onofrio, M., Brandi, R., Cattaneo, A., Bertolazzi, P., Cumbo, F., Felici, G., & Guerra, C. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0155-5 · Cited by 3
Santos, G., & Díaz, M. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212181 · Cited by 3
Self-citationA Perspective: Challenges in Dementia Research
Stecker, M. M. (2022) · Medicina · doi:10.3390/medicina58101368 · Cited by 3
Tauopathy in the APP swe / PS1 ΔE9 mouse model of familial Alzheimer’s diseasePreprint
Metaxas, A., Thygesen, C., Kempf, S. J., Anzalone, M., Vaitheeswaran, R., Petersen, S., Landau, A. M., Audrain, H., Teeling, J. L., Darvesh, S., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/405647 · Cited by 4
Metadata
- Authors
- Aso, E., Lomoio, S., López‐González, I., Joda, L., Carmona, M., Fernández‐Yagüe, N., Moreno, J., Juvés, S., Pujol, A., Pamplona, R., Portero‐Otin, M., Martín, V., Díaz, M., & Ferrer, I.
- Affiliations
- Bellvitge University Hospital (ES)
- University of Pavia (IT)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Universitat de Lleida (ES)
- Universidad de La Laguna (ES)
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2012-01-13
- Volume
- 22
- Issue
- 5
- Pages
- 636-653
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- PMC
- PMC8057644
- OpenAlex
- W1869566076
- Cited by
- 118
- References
- 73
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 4 · 2021: 11 · 2020: 9 · 2019: 10 · 2018: 9 · 2017: 4 · 2016: 11 · 2015: 10 · 2014: 14 · 2013: 9 · 2012: 6
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by-nc-nd)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- familial Alzheimer's disease, APP/PS1 mice, amyloidogenesis, amyloid plaques, beta-secretase 1, BACE1, Swedish mutation, presenilin 1, proteasome, ubiquitin-proteasome system, mitochondrial dysfunction, oxidative damage, dystrophic neurites, post-translational modification, disease progression, memory impairment
- MeSH terms
- Superoxide Dismutase-1, Age Factors, Alzheimer Disease, Animals, Avoidance Learning, Brain, Cognition Disorders, Cysteine Endopeptidases, Disease Models, Animal, Gene Expression Regulation, Humans, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Neuropsychological Tests, RNA, Messenger, Superoxide Dismutase, Signal Transduction, Amyloid beta-Peptides, Microscopy, Immunoelectron, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, tau Proteins, Disease Progression, Mitogen-Activated Protein Kinases, Recognition, Psychology, Ubiquitin Thiolesterase, Microscopy, Electron, Transmission, Proteasome Endopeptidase Complex, Mice, alpha-Synuclein, Presenilin-1, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
